Limited data: Only 1 submission available. Results should be interpreted with caution.

Aggregate Statistics

1 Total Submissions
8/10 Avg. Effectiveness
-100 NPS Score
14 days Time to Notice
30 days Time to Peak
100% Would Use Again
8 weeks Avg. Cycle Length
100% High Confidence

Effectiveness Distribution

1
2
3
4
5
6
7
8
9
10

Distribution of effectiveness ratings (1-10)

Administration Methods

Subcutaneous 1

Recommendation Score Distribution (NPS)

-100
0 Promoters (9-10) 0 Passives (7-8) 1 Detractors (0-6)
0
1
2
3
4
5
6
7
8
9
10

How likely would users recommend this peptide? (0-10)

Effect Persistence After Stopping

Still ongoing
1 (100%)

Side Effects Analysis

Most Reported Side Effects

Injection site reactions Avg severity: 2/5
1
irritability Avg severity: 2/5
1

Onset Timing

Early (1st week) 1

Resolution Status

N/A 1

Individual Submissions

Have experience with Abaloparatide?

Share Your Findings